ERBB2 and breast cancer: We next examined the function of the CAR T cells transduced with each of the promoter constructs, measuring cytokine release (IL-2 and IFN-γ), cytotoxicity and activation following incubation of CAR T cells with the Her2+ MCF-7 breast cancer cell line.